New Horizon Health Gets Booster with New Product Approval

Company says its UU Tube used to self-screen for stomach cancer has been approved by China’s health regulator Key takeaways: New Horizon Health says its first-of-its-kind UU Tube self-screening product for stomach cancer has been approved for sale in China Company is already frothily valued compared with peers, though sales from new device could bring that down to healthier levels By Tina Yip Think back to last February when a hot Hong Kong biotech IPO wowed investors with a story of big riches from its early colorectal cancer screening kits.…

Read More »

Connect Biopharma’s Latest Dermatitis Drug Update Fails to Pump Up Shares

Company’s stock sank after it released data on Phase 2b trials for its atopic dermatitis drug, a potential competitor to Regeneron-Sanofi blockbuster Dupixent Key takeaways: Loss-making Connect Biopharma says Phase 3 clinical trials of its CBP-201 drug for atopic dermatitis will begin in second half of this year Connect Biopharma shares, which more than halved after its November release of initial Phase 2 clinical trial data, fell further after latest update By Mia Shanley China’s Connect Biopharma Holdings Ltd. (CNTB.US) is just itching to bring in its first-ever revenue with…

Read More »